Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris

ClinicalTrials.gov ID: NCT01241331

Public ClinicalTrials.gov record NCT01241331. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 1:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Controlled Evaluation of the Safety and Efficacy of a Topical Treatment for Moderate-Severe Facial Acne Vulgaris

Study identification

NCT ID
NCT01241331
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Braintree Laboratories
Industry
Enrollment
233 participants

Conditions and interventions

Conditions

Interventions

  • BLI1100 Drug
  • Vehicle cream Drug

Drug

Eligibility (public fields only)

Age range
12 Years to 45 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2010
Primary completion
Mar 31, 2011
Completion
Not listed
Last update posted
Sep 30, 2012

Started 2010

United States locations

U.S. sites
20
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Center for Dermatology Clincal Research Fremont California 94538
Dermatology Research Associates Los Angeles California 90045
Dermatology Specialists Oceanside California 92056
Horizons Clinical Research Center Denver Colorado 80220
North Florida Dermatology Associates Jacksonville Florida 32204
Ameriderm Research Ormond Beach Florida 32174
Atlanta Dermatology, Vein and Research Center Alpharetta Georgia 30022
Peachtree Dermatology Associates Research Center Atlanta Georgia 30327
Northwest Clinical Trials Nampa Idaho 83686
The Indiana Clinical Trials Center Plainfield Indiana 46168
The South Bend Clinic South Bend Indiana 46617
Minnesota Clinical Study Center Fridley Minnesota 55432
Academic Dermatology Associates Albuquerque New Mexico 87106
Clinical Partners Johnston Rhode Island 02919
DiscoveResearch Bryan Texas 77802
Progressive Clinical Research San Antonio Texas 78229
Dermatology Research Center Salt Lake City Utah 84124
The Education and Research Foundation Lynchburg Virginia 24501
Virginia Clinical Research Norfolk Virginia 23507
Premier Clinical Research Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01241331, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 30, 2012 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01241331 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →